drugset / Trial / NCT00508365

Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives

NCT00508365

Phase 1 Completed 62 enrolled GlaxoSmithKline
RandomizedCrossoverTreatment

Summary

This is a multi-center, double-blind, randomized, placebo-controlled, 2-session crossover study to evaluate the incidence of orthostatic hypotension in elderly hypertensive subjects following co-administration of carvedilol CR and lisinopril.

Timeline

Start
2007-09-25
Primary completion
2008-06-03
Completion
2008-06-03

Publications

  • Background GSK has submitted manuscripts of these study results to peer-reviewed scientific journals which were not accepted for publication. GSK is providing the attached study results summary with a conclusion.

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 20 mg Oral
Subject Carvedilol Other / unclassified 40 mg Oral
Subject LISINOPRIL ANHYDROUS Small molecule 10 mg Oral

Indications